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ABSTRACT
The respiratory tract opens to the external environment at the oral side edge, and the other edge of the respira-
tory tract connects to the closed space (alveoli), and so to preserve the sterility in the terminal respiratory tract
is critical for protection against pathogens. The recognition machinery for the invasion of microbes is indispen-
sable for the preservation of the sterility in the lungs. Our general understanding of how microbes are recog-
nized by the innate immune system has increased considerably over the past several years, and the contribu-
tion of Toll-Like Receptors (TLRs) to innate immunity is now well documented. In the meantime, it has come to
understand that many inflammatory processes may depend on TLR signaling, it has been considered to be in-
volved in the pathogenesis of airway inflammatory diseases such as airway infections, bronchial asthma, and
occupational airway diseases. In this review, we focus on physiological roles of TLRs in defense mechanisms
of the airways, and pathophysiological roles on airway diseases.
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INTRODUCTION
The alveoli of the lungs that facilitate and are thereby
a vital part of the gas exchange process: they are the
terminal of the respiratory tree. To carry out efficient
gas exchange, the respiratory system and the circula-
tory system get to within a few microns distance of
each other. Alveolar type-I epithelial cells, which oc-
cupy 90% of the surface area of the alveoli, are special-
ized in facilitating the gas exchange process, and
therefore they do not have a significant role to play in
defending against infections. These particular fea-
tures of the organizational structure of the alveoli are
a disadvantage in terms of the defense against infec-
tions, as the invasion of microbes into the alveolar
area facilitates the entry of pathogens into the circula-
tory system, which can result in sepsis and thereby
incur the risk of death.
For these physiological and anatomical reasons,
the lungs are kept aseptic via various protective
mechanisms. The respiratory tract opens to the exter-
nal environment at the oral side edge, and the other
edge of the respiratory tract connects to the closed
space (alveoli), in a semi-closed circuit, and so steril-
ity in the respiratory tract increases incrementally
from the upper to the lower airway. Neither the tra-
chea nor the relatively large bronchi are aseptic;
moreover, because microbes enter frequently from
the oral cavity, these organs have to protect them-
selves from microbes largely through actions like
mucous secretions, or mucociliary movements. The
final bifurcation of the bronchi is the alveolar bronchi-
ole where the bronchi and the alveoli coexist; it is be-
lieved that this area, corresponding to the entrance of
the alveoli, is maintained aseptic. The recognition ma-
chinery for the invasion of microbes is critical to pre-
serve the aseptic condition.
TLR-MEDIATED INNATE IMMUNE RECOG-
NITION
Innate immunity refers to a built-in defense system of
the host to resist the invasion of microbes. The recog-
nition of microbes by an innate immune system has
been considered to play a key role in the mainte-
nance of the aseptic condition. Our general under-
standing of how microbes are recognized by the in-
nate immune system has increased considerably over
the past several years, and the contribution of Toll-
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Like Receptors (TLRs) to innate immunity is now
well documented.1-5 The discrimination between
“self” and “nonself” by TLRs as sensors of pathogen
molecules, is a key mechanism of the immune sys-
tem response. For mammals to be able to detect
pathogens, a common strategy used by multiple TLR
family members is the targeting of constitutents as an
indicator of infectious non-self. It now seems that
many inflammatory processes may depend on TLR
signaling.6-8 To date, about 15 mammalian TLRs have
been reported.1,2,4 For example, TLR4 recognizes
lipopolysaccharide (LPS) a common constituent of
the cell wall of gram-negative bacteria and TLR2 rec-
ognises peptidogylcan a common constituent of
gram-positive cell walls, both of which are critical for
the innate immune response against bacterial inva-
sion.1-5 TLR3, TLR7, TLR8, and TLR9 recognize
pathogen nucleic acids, such as viral RNAs and bacte-
rial DNA.1-5 TLR activation results in the engagement
of signaling intermediates, including the following:
myeloid differentiation factor-88 (MyD88); Toll-inter-
leukin (IL)-1 receptor (TIR)-associated protein (TI-
RAP, also known as MAL); Toll receptor-associated
activator of interferon (TRIF); Toll receptor-asso-
ciated molecule (TRAM); IL-1 receptor-associated
kinases (IRAK) and tumour necrosis factor (TNF)
receptor-associated factor 6 (TRAF6).1-5 RNA virus in-
fections such as respiratory syncytial virus (RSV) or
influenza virus, are the major causes of virus-induced
airway inflammation.9-11 Detection of the “molecular
signature” for RNA viruses has been attributed to
TLR3, TLR7, and TLR8. Double-stranded RNA
(dsRNA) is a molecular pattern which is associated
with viral infection, because it is produced by most vi-
ruses at some point during their replication proc-
ess.12-16 TLR3 has been shown to recognize dsRNA,
and the binding of dsRNA to TLR3 activates signaling
to induce anti-viral responses.17 TLR7 and TLR8 have
been described as mediating the immune response to
guanine and urachil (GU)-rich single-stranded RNA
(ssRNA) viruses.18-20 TLR3, TLR7, and TLR8 have
been shown to be endosomally located.21,22 TLR3 is
also constitutively expressed on the surface of airway
epithelial cells.23 The surface expression of TLR3 rec-
ognizes extracellular dsRNA but if TLR3 expression
is blocked, the antiviral response to the RNA virus is
inhibited which leads to an increase in viral replica-
tion and release.23 TLR3, TLR7, and TLR8 can each
signal independently of MyD88, via a Tollinterleukin
1 (IL-1) receptor domain containing adaptor-inducing
beta interferon (IFN-β) (TRIF); this independent sig-
naling, leads to NF-kB activation and production of
type-I interferon which plays an important role in the
innate immune response against viral infection.13,16
Not only innate immune responses, different types
of adaptive immune responses are also induced via
several TLRs expressed on dendritic cells or mono-
cytes. Functioning of the adaptive immune system is
based on a diverse set of rearranged T cell receptors
and B cell receptors that recognize a wide variety of
antigens. Although T and B lymphocytes express re-
ceptors of enormous diversity, their activation de-
pends on signals derived from the innate immune
system. Immature DCs residing in the periphery are
incapable of inducing T cell priming, and TLRs on DC
play important role on the DC maturation. When
TLRs on DC recognize their ligands, the initiate sig-
naling that lead to DC maturation cause up-regulation
of MHC molecules loaded with pathogen-derived pep-
tides and surface expression of co-stimulatory mole-
cules, such as CD80 and CD86. The TLR-mediated
control of co-stimulatory molecule expression on DC
plays a crucial role in T cell activation.24
TLRS IN BRONCHIAL EPITHELIAL CELLS
The lung have multiple regulatory mechanisms to
maintain the aseptic condition of the terminal airway,
and the alveolar macrophages, which specialize in
monitoring microbes in the alveoli, provide complete
protection by triggering a strong inflammation reac-
tion when microbes are found.25,26 On the other
hand, regarding the monitoring of microbes in the
bronchi, bronchial epithelial cells are on front-line of
defense against infections.27-30 Most TLRs expression
in airway epithelial cells have been documented in re-
search using either cell lines, primary cells or tis-
sues,31-35 but thir exact expression patterns and ex-
pression levels are still to be elucidated. From the
aforementioned differences in the levels of sterility,
the central bronchi and the peripheral bronchi seems
to have different roles in terms of how they monitor
microbes; however, there have been few reports up
until now that have shown any notable differences in
TLR expression level between the central bronchial
epithelium and the peripheral bronchial epithelium.
Additionally, there have been few reports that verify
any apparent differences in responsiveness to the
TLR ligand in cultured bronchial epithelial cells de-
rived from the central airway or the peripheral air-
way. The culture experiments, using bronchial epi-
thelial cells, showed differences in responsiveness to
the LPS between the bronchial epithelium and the
monocytemacrophage linage. For the macrophages
and monocytes, the LPS response was observed with
only a minimal nM of concentration. On the other
hand, for the tracheal epithelium, the response re-
quired more than 100 times that minimal concentra-
tion, thus showing a clear difference in sensitivity to
LPS.27,36,37 As to responses to the peptidoglycan and
dsRNA, which are ligands within the same TLR, such
a significant difference in sensitivity has not been ob-
served.38-40 It is believed that this difference stems
from the different roles of the tracheal epithelial cells
and the monocytemacrophage series in monitoring
microbes.
There are some differences in patterns of the se-
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creted cytokine response to TLR ligands between the
bronchial epithelium and macrophages. For example,
TNF is a representative cytokine that is produced
from alveolar macrophages when they are stimulated
with TLR,40 but there is little evidence to indicate that
the differentiated bronchial epithelial cells can pro-
duce TNF.41 TNF itself has strong inflammation in-
duction effects as well as tissue damage effects. The
fact that bronchial epithelial cells do not produce
TNF can be rationalized by the fact that the main pur-
pose of the monitoring of microbes by the bronchial
epithelial cells is not to induce inflammations strong
enough to cause tissue destruction but rather to
achieve the recruitment of neutrophils by chemotaxis
as an initial response to the entry of microbes.
ALLERGIC AIRWAY INFLAMMATION AND
TLRS
Bronchial asthma is a complex inflammatory disease
of the airways that is associated with bronchial hyper-
reactivity, airway obstruction, and increased mucus
production. The imbalance between TH1 and TH2
lymphocytes with a predominant TH2-type immune
response is a central component in the regulation and
perpetuation of the asthma pathology.42-44 The re-
lease of TH2 cytokines including IL-4, IL-5, and IL-13
in response to allergen exposure induces recruitment
and, activation of eosinophils, mast cell activation,
and the switch to IgE production by B cells in asth-
matics.44,45 The inverse relationship between micro-
bial load in childhood and later development of aller-
gic diseases has led to the hygiene hypothesis,46-49
this hypothesis was first proposed by David P.
Strachan in an article published in the British Medi-
cal Journal in 1989.50 This hypothesis has now been
developed to an understanding that frequent expo-
sure to microbial products results in a predominant
TH1 phenotype, whereas a lack of such interactions
could promote TH2-driven allergic diseases. This “hy-
giene hypothesis” proposes that infections acquired
early in life may protect children against asthma.
Gram-negative bacteria, mycobacteria and many vi-
ruses strongly induce TH1 responses.49 These patho-
gens, or their purified components, have been shown
to prevent TH2-type responses in animals.51 The hy-
giene hypothesis is strengthened by certain epidemi-
ological evidence and by the recent discovery that
polymorphisms in CD14, an LPS coreceptor, are asso-
ciated with an increased asthma risk in children.52-54
These genetic variants of CD14 may reduce the inten-
sity of LPS responses, thereby reducing development
of TH1-type immunity, LPS though appears to have
paradoxical roles depending on the timing and the
context of the LPS exposure. Although early expo-
sure to LPS (or other TLR ligands) can decrease the
incidence of atopic asthma in later life,55 many re-
ports have demonstrated an increase in allergen-
induced asthma severity following exposure to
LPS.56,57 Viral infection during the first 3 years of life
greatly enhances the risk of asthma in children, sug-
gesting that specific interactions between respiratory
allergies and viral infections in the respiratory tracts
exists; especially, RSV infection in respiratory viral in-
fections, in early childhood, might enhance the devel-
opment of airway allergen sensitization.58,59 A replica-
tion intermediate of RSV is dsRNA, and several stud-
ies have revealed that TLR3 and dsRNA lead to the in-
duction of genes related to the pathogenesis of bron-
chial asthma. Thymic stromal lymphopoietin (TSLP)
has been shown to be highly involved in the patho-
genesis of inflammatory diseases in general.60 High
TSLP expression has been found in the skin of pa-
tients with acute and chronic atopic dermatitis, while
TSLP is not detectable in normal skin or in nonle-
sional skin of atopic dermatitis patients.61 In addition,
TSLP has been found to be increased in asthmatic air-
ways.62 High amounts of TSLP have been found in
bronchoalveolar lavage fluid in a mouse asthma
model and lung-specific TSLP transgenic mice show
airway inflammation including massive infiltration of
inflammatory cells, goblet cell hyperplasia, and air-
way hyper responsiveness,63 whereas mice lacking
the TSLPR exhibit strong TH1 responses and fail to
develop an inflammatory lung response to antigens.64
A recent study revealed that TSLP strongly and sig-
nificantly induced TLR3 ligand and that the combina-
tion of IL-4 and dsRNA synergistically enhanced
TSLP production in airway epithelial cells;65 this indi-
cates that respiratory viral infection and the recruit-
ment of TH2 cytokine-producing cells may amplify
TH2 inflammation via the induction of TSLP into the
asthmatic airway.
ENVIROMENTAL AIRWAY INFLAMMATION
AND TLRS
Environmental substances reportedly have a complex
effect upon the airway, and epidemiologic studies
have shown that asthma-related hospital emergency
room visits increase during periods of increased lev-
els of particulate matter less than 10 micrometers in
diameter (PM10).66,67 Residual oil fly ash (ROFA) pro-
duced from the combustion of residual fuel oil signifi-
cantly increases the ambient air pollution. In human
airway epithelial cells, ROFA has been shown to in-
duce inflammatory cytokines, such as IL-6, IL-8, and
TNF-α.67 Inhalation of ROFA into the airways of ex-
perimental animals, as surrogates, has been an ac-
ceptable model to study the biologic effects of PM10
air pollution.68 Furthermore, ROFA reportedly causes
increased airway hyperreactivity, neutrophilic inflam-
mation, and hyperpermeability in animal models68
and can amplify allergic inflammation in mouse mod-
els of asthma.69 Cho HY et al. have reported that sig-
nificant interstrain (genetic) variation was observed
in ROFA-induced lung inflammation and hyperperme-
ability phenotypes.70 C3HHeJ (HeJ) mice were most
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resistant to the ROFA-induced airway inflammation
responses. They observed that ROFA-induced lung
injury was significantly greater in CH3OuJ mice
compared with HeJ mice. CH3OuJ mice have nor-
mal TLR4, on the other hand, CH3HeJ mice have a
missense mutation in the tlr4 gene, resulting in non-
functional TLR4. They also found that ROFA signifi-
cantly enhanced transcript and protein levels of lung
TLR4 in OuJ but not in HeJ mice, and they observed
greater activation of downstream signal molecules,
such as MYD88, TRAF6, IRAK-1, NF-kappaB,
MAPKs, and AP-1 was observed in OuJ mice than in
HeJ mice before the development of ROFA-induced
airway injury.
Ozone is another ubiquitous urban air pollutant
that can significantly contribute to increased pulmo-
nary morbidity and mortality in human populations.71
Despite the demonstrated clinical relevance of ambi-
ent ozone, the biological mechanisms of ozone-
induced airway inflammation have remained to be
elucidated. Humans exposed to ozone develop neu-
trophilic inflammation, increased expression of proin-
flammatory cytokines, and decrements in pulmonary
function.72 Interestingly, TLR4 level has been re-
ported to be strongly linked to the sensitivity of the
airway to ozone.73 This evidence indicates that TLR4
might be a candidate susceptibility gene for environ-
mental airway diseases.
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